Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeEXECUTIVESOne Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

One Drop, a leader in precision health solutions for people living with chronic conditions, today announced Carrie Siragusa, CPA, as VP of Commercial Strategy.

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Siragusa brings more than 15 years of financial, operational, and marketing experience in public and private organizations in the pharmaceutical, health sciences, and life sciences industries to One Drop. Before joining One Drop, Siragusa led the Innovation and Diabetes Portfolio team at Sanofi, a leading global biopharmaceutical company focused on human health. While at Sanofi, Siragusa was responsible for leading marketing for key diabetes brands and managing patient support programs. She also served as the US lead for the organization’s integrated care offerings. Prior to Sanofi, Siragusa served as an auditor at EisnerAmper LLP, a leading full-service accounting and advisory firm. Siragusa is a Certified Public Accountant (CPA).

“We are thrilled to have Carrie join our team to help accelerate the use of our predictive technology to empower people living with chronic conditions,” said Jeff Dachis, One Drop CEO and founder. “Carrie’s expertise in innovation within the diabetes space will be an incredible asset to One Drop as we explore ways to make continuous glucose monitoring more accessible and affordable to all.”

Siragusa will report to Rachel Yap Martens, SVP of Commercial Strategy and Innovation. Together, they will bring One Drop’s multi-analyte dermal biosensor to market, making continuous health sensing more accessible and available at a lower cost to people living with type 1 diabetes, type 2 diabetes, and other chronic conditions. In her new role, Siragusa will work closely with Ashwin Pushpala and Matthew Chapman, SVPs of Biosensor Development. The biosensor will generate a continuous stream of thousands of additional data points per member per day, offering exponential growth of the 26 billion existing health data points powering One Drop’s predictive, AI-enabled platform.

“Our team is laser-focused on making continuous health sensing technology available to a broader at-risk audience,” said Yap Martens. “When coupled with One Drop’s telehealth platform and predictive capabilities, our biosensors will have the power to deliver personalized, preventative care to millions of more people worldwide, empowering them to take charge of their health today for a better, healthier tomorrow.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy and liquefy tissue in the liver without incisions, ionizing radiation or heat.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy